NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
Clinical Trials
7 trialsNCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
NCT03324815 2017-10-30
Methadone Associated With Morphine for Cancer Pain
Federal University of São Paulo
Phase NA Unknown
NCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT00184496 2014-02-28
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
Norwegian University of Science and Technology
Phase 3 Completed
NCT00525967 2007-09-06
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
Faculdade de Medicina do ABC
Phase 2/3 Unknown